To ask the Secretary of State for International Development, what steps her Department is taking to incentivise the development of new drugs to treat TB.
DFID has supported the development of new drug combinations to treat TB since 2005. Funding is provided to the TB Alliance, a product development partnership (PDP). PDPs bring together partners from the public, private and philanthropic sectors to develop new products in a way that de-links the cost of development from the final cost of product. The TB Alliance is currently testing a number of new drugs combinations to simplify and shorten TB treatment times and provide new treatment options for drug resistant TB.
In addition we committed in our manifesto to lead a major new global programme to accelerate the development of vaccines and drugs to eliminate the world’s deadliest infectious diseases. In November the Chancellor announced the new £1 billion Ross Fund which will deliver on this commitment. The Ross Fund will target infectious diseases including malaria and tuberculosis, supporting work to develop, test and deliver a range of new products (including vaccines, drugs and diagnostics) to help combat these diseases in developing countries.